CytoSMART Technologies has appointed Dr. Peter Djali and Bill Rhodes as members of its supervisory board, with Rhodes to serve as chairman of the board. Djali previously served as European Union sales director at Essen Bioscience and sales manager at Molecular Devices. Djali has a Ph.D. in molecular physiology. Rhodes worked as an executive officer of Becton, Dickinson, and Co. and worldwide president of BD Biosciences. He is also chairman of the board of OpGen Inc. and interim chairman of the board of Omega Diagnostics Group plc. He serves in various capacities at Cornell University and is an adviser to Altaris Capital Partners, a New York City-based health care private equity firm.